Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, explains trends he expects to see in upcoming diabetes and weight loss studies.
Time-restricted eating and other fasting weight loss methods can help improve metabolic outcomes, said Marc-Andre Cornier, MD, endocrinologist, professor, and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina.
Transcript
What are you looking forward to regarding the future of research on weight loss and diabetes?
I think that's a hot area of, you know, is it more important when you eat or is it more important what you eat and how much you eat? It's probably a combination of all those things.
But there's a growing repository of studies looking at time-restricted eating, alternate-day fasting, [and] intermittent fasting. These terms are not interchangeable. These are different things. But these offer patients another option and and are potentially important also for metabolic outcomes, as well.
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More